A 13-year-old girl with acute lymphoblastic leukemia (ALL) Methods developed extremely high plasma triglyceride (TG) concentrations of 103 mmol/l (reference value Ͻ1.8 mmol/l) during Fasting blood samples were drawn into vacutainer tubes concombination treatment with corticosteroids and asparaginase. taining 1.5 mg/ml Na 2 EDTA. Plasma was prepared from blood Corticosteroids are known to induce the production of TG-rich within 2 h. The plasma was stored until analysis at −80°C.
Introduction
Results l-Asparaginase in combination with corticosteroids is commonly used in the treatment of children with acute lympho-
Case report
blastic leukemia (ALL). 1 The drug exerts its chemotherapeutic effect by hydrolysing l-asparagine and thereby depleting the A 13-year-old girl, height 1.64 m, weight 57 kg, presented supply of this amino acid to leukemia cells, which are unable with a history of general discomfort. Some hematomas but no to initiate de novo synthesis of l-asparagine.
2,3 A possible cutaneous xanthomas were present at physical examination. adverse reaction of l-asparaginase, especially if used in com-A blood smear showed leukemic blasts. Bone marrow analysis bination with corticosteroids, is an elevation in plasma triglyrevealed 95% leukemic blasts (FAB-L1 classification) and supceride (TG) concentration, 4 which is reported to occur in up pression of normal hemopoiesis; immunophenotyping conto 10% of children treated. 5 The mechanism responsible for firmed the diagnosis of pre-B ALL. Liver functions, serum gluthe hypertriglyceridemia is unknown, but a relationship with cose and serum cholesterol (4.1 mmol/l) were normal. Thyroid lipoprotein lipase (LPL) has been suggested. 5 LPL is an function was normal. Remission induction treatment was endothelial-bound enzyme responsible for triglyceride started with a regimen of the Dutch Childhood Leukemia hydrolysis of circulating TG-rich lipoproteins. 6 It is the rateStudy Group containing prednisone (60 mg/m 2 days 1-29, limiting enzyme for the removal of TG from the circulation 6, 7 tapered off days 29-38), vincristine (1.5 mg/m 2 days 8, 15, and the fasting plasma concentration of TG correlates with the 22, 29), daunorubicin (30 mg/m 2 days 8, 15, 22, 29) and lactivity of LPL. 8 Upon therapy with corticosteroids, an extenasparaginase (Erwinia derived, 10 000 IU/m 2 at days 18, 22, sive production of TG-rich lipoproteins occurs.
9,10 On the 25, 28 and 31). At day 34 of treatment, when the patient was other hand, corticosteroid treatment results in increased LPL in complete remission, she became weak and lethargic; the activity, 11, 12 which is thought to be sufficient to prevent serum appeared lactescent. Plasma triglyceride (TG) was 103 extreme hypertriglyceridemia in patients treated with corticommol/l (reference: Ͻ1.8 mmol/l); plasma cholesterol was steroids only. In our patient, who showed 50-fold increased 7.6 mmol/l (reference: Ͻ5.0 mmol/l). l-asparaginase treatment TG levels after therapy with corticosteroids and l-asparaginwas postponed until days 42 and 45, when plasma triglyceride ase, we studied the effect of treatment with corticosteroids and levels were decreased ( Figure 1 ). Subsequently, the patient l-asparaginase on the activity of LPL.
was treated with four courses of high-dose methotrexate (2 g/m 2 ) in 8 weeks. Two weeks later, reinduction treatment (dexamethasone 10 mg/m 2 for 18 days, thereafter tapered off in 9 days; vincristine and doxorubicin) was started. To prevent increased apoB concentration as well ( Table 1 ). The LPL activity of both parents was within the normal range.
Lipase activity
Pretreatment lipid analyses were not available except for a normal serum cholesterol level of 4.1 mmol/l. However, during maintenance therapy with 6-mercaptopurine and methotrexate, drugs not known to interfere with lipid metabolism, a normal LPL activity was seen ( Figure 1 and Table 2 ). Upon treatment with corticosteroids, a steep increase in LPL activity occurred (Figure 1, day 136 ), followed by a rapid decrease to values below reference activity upon therapy with l-asparaginase (Figure 1, day 153) . This decrease in LPL activity was paralleled by an increase in serum triglyceride levels from 4.5 this condition, a spectacular rise in serum triglyceride and cholesterol levels occurred ( Figure 1 , Table 2 ). may be explained by a corticosteroid-induced increase in LPL activity. 11, 12, 15 These effects of corticosteroids on TG concenChol, cholesterol; TG, triglyceride; HDLc, high-density lipoprotein tration and on LPL activity were also present in our patient.
cholesterol; apoB, apolipoprotein B; LPL, post-heparin lipoprotein However, our data also suggest that l-asparaginase treatment lipase activity.
resulted in a decrease of LPL activity. The combination of an increased TG synthesis by corticosteroids and a decrease in the activity of LPL during l-asparaginase treatment resulted in menorrhea, lynestrenol 5 mg per day, was given during the a situation in which TG-rich lipoproteins were rapidly formed whole period. but insufficiently cleared from the plasma. As a consequence, The family history was negative for cardiovascular disease.
extremely high TG levels occurred. Both parents were in good health. The father, 50 years of age,
The mechanism by which asparaginase exerts its effect on has a mild hypertriglyceridemia with a low HDLc and an LPL activity is not known. It may act via a reduction in protein increased apoB concentration ( Table 1 ). The mother is 48 synthesis: asparaginase is known, in general, to decrease proyears old, has a very mild hypercholesterolemia and an tein synthesis. 2 It is puzzling why only less than 10% of the ALL patients treated with asparaginase and corticosteroids Table 2 The effects of chemotherapy on fasting plasma lipids, develop a marked hypertriglyceridemia. 5 Whether or not a lipase activity and insulin in a 13-year-old girl with ALL patient develops hypertriglyceridemia may be dependent on the balance between TG synthesis and TG clearance. In our We propose that the pre-existence of an increased VLDL bined treatment of corticosteroids and asparaginase.
